Cortechs.ai | Home
Cortechs.ai|Home
Cortechs.ai|Home

Our approach to enhanced diagnostics

As the pioneer of brain segmentation, our latest evolution of cutting-edge software solutions use advanced AI to provide insights and analysis to clinicians, optimize radiology workflows, and improve detection and validation of disease across care pathways

Our solutions

Best-in-class brain segmentation and volumetric analysis
Accurately visualize lesions and lesion volume change.

Pre- and post-operative 3D volume analysis of brain tumors.

Automated tracer activity quantification

Automated CT alignment for fast, accurate diagnosis

Segmentation and longitudinal tracking of FLAIR, T2*GRE, and SWI lesions

Optimizing prostate MRI for advanced clinical insights.

Cortechs.ai|Home
Quantifying for 18+ years
Cortechs.ai|Home

2,000,000+ brains scanned

Cortechs.ai|Home

Trusted by 1500+ medical institutions

Cortechs.ai|Home

Available in 44 countries

Cortechs.ai|Home
Zero downtime

In the Spotlight

Our customers

Our technology partners

Where in the world is Cortechs.ai?

Insights

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.
Scroll to Top